GLOBUS MEDICAL INC (GMED) — SEC Financial Statements & Analysis

GLOBUS MEDICAL INC (GMED) is a surgical & medical instruments & apparatus company, incorporated in DE. GLOBUS MEDICAL INC trades on NYSE as: GMED. GLOBUS MEDICAL INC (GMED)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, GLOBUS MEDICAL INC carries a market cap of $10.67B, a P/E ratio of 19.93x, a P/B ratio of 2.24x, a P/S ratio of 3.39x, an enterprise value of $10.16B, and an EV/EBITDA multiple of 11.05x. On profitability, it posts a gross margin of 68.55%, an operating margin of 20.34%, a net margin of 17.03%, a Return on Equity (ROE) of 11.81%, a Return on Assets (ROA) of 10.25%, and a Return on Invested Capital (ROIC) of 12.29%. Per share, it reports EPS of $3.96, diluted EPS of $3.90, free cash flow per share of $5.59, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 19.74% year-over-year, net income growth of 50.13% year-over-year, and EPS growth of 50.30% year-over-year. On the balance sheet, it maintains a current ratio of 4.62x, a quick ratio of 2.78x, working capital of $1.74B, a debt-to-equity ratio of 0.15x, a debt ratio of 0.13, an interest coverage ratio of 45.80x, free cash flow of $755.59M (TTM), and net debt of $-507.75M. Figures sourced from SEC EDGAR.

Market Cap

$10.67B

P/E TTM

19.93x

EPS TTM

$3.96

P/B TTM

2.24x

ROE TTM

11.81%

ROA TTM

10.25%

Debt To Equity

0.15x

Free Cash Flow TTM

$755.59M

Net Revenue TTM Growth 1Y

19.74%

Data as of 2026-06-30 · Source: SEC EDGAR